Brian Kesselmeyer
About Brian Kesselmeyer
Brian Kesselmeyer is the Manager of Continuous Improvement at Bristol Myers Squibb in Warren, New Jersey, with extensive experience in biotechnology and cell therapy manufacturing.
Current Position at Bristol Myers Squibb
Brian Kesselmeyer currently holds the position of Manager Continuous Improvement at Bristol Myers Squibb in Warren, New Jersey, United States. His role focuses on optimizing processes and enhancing efficiency within the company. His skills and experience in continuous improvement serve to drive operational excellence at Bristol Myers Squibb.
Previous Roles at Bristol Myers Squibb
Prior to his current role, Brian Kesselmeyer was the Associate Manager Continuous Improvement at Bristol Myers Squibb from 2019 to 2021. During these two years, he contributed to the company’s efforts in process optimization. His tenure at Bristol Myers Squibb showcases his growing responsibilities and expertise in continuous improvement within the biotechnology sector.
Experience at Celgene
Brian Kesselmeyer has had multiple roles at Celgene, starting as a Laboratory Technologist from 2015 to 2017. He then served as a Specialist for five months in 2018 before becoming a CAR-T Manufacturing Supervisor from 2018 to 2019. His responsibilities included overseeing CAR-T cell therapy manufacturing processes, which align with his strong background in GMP (Good Manufacturing Practices) and SOP (Standard Operating Procedures).
Role at Celularity, Inc.
From 2017 to 2018, Brian Kesselmeyer worked at Celularity, Inc. as a Senior Laboratory Technologist. During his four months at the company, he focused on advanced laboratory techniques. This role further expanded his expertise in cell culture techniques and biotechnology product development.
Educational Background
Brian Kesselmeyer has a solid educational foundation in biology and mechanical engineering. He earned a Bachelor of Science in Biology from Marist College, studying from 2009 to 2012. Before this, he studied Mechanical Engineering at the Rochester Institute of Technology for one year from 2008 to 2009. This diverse academic background has provided him with a robust understanding of both biological processes and engineering principles.